Pacific Biosciences of California, Inc. (PACB) has entered into a Sales Agreement with Allen & Company LLC to sell shares of its common stock with aggregate gross proceeds of up to $100 million. The sales will be conducted from time to time through an "at-the-market" (ATM) equity offering program.

Key Details

  • Offering Size: The company may sell shares of its common stock for aggregate gross proceeds of up to $100,000,000.
  • Agreement: The Sales Agreement was made with Allen & Company LLC, acting as the sales agent, on November 10, 2026.
  • Sales Agent Compensation: Allen & Company LLC is entitled to a commission of up to 3.0% of the aggregate gross proceeds from shares sold under the agreement.
  • Terms: Pacific Biosciences will control the parameters of the sales, including the number of shares, timing, and minimum price. The company has no obligation to sell any shares under the program.